- Mediso NanoScan PET/CT system
- Use a radiolabeled antibody to detect an early marker of Alzheimer’s Disease.
- Track bone regeneration in the presence of a hydrogel scaffold.
- Measure degradation over time of implanted bioresorbable devices.
Recent PET/CT publications
Bioresorbable pressure sensors protected with thermally grown silicon dioxide for the monitoring of chronic diseases and healing processes.
Shin J, … Rogers JA. Nat Biomed Eng. 2019 Jan;3(1):37-46. DOI link Continue Reading Bioresorbable pressure sensors protected with thermally grown silicon dioxide for the monitoring of chronic diseases and healing processes.
Zhang H, … Rogers JA. Sci Adv. 2019 Mar 8; 5(3):eaaw0873. DOI link Continue Reading Wireless, battery-free optoelectronic systems as subdermal implants for local tissue oximetry.
Fully implantable optoelectronic systems for battery-free, multimodal operation in neuroscience research
Gutruf P, … Rogers JA. Nat. Electronics 2018 Dec; 1(12): 652-660. DOI link Continue Reading Fully implantable optoelectronic systems for battery-free, multimodal operation in neuroscience research
In April 2015, a Mediso nanoScan Positron Emission Tomography (PET) scanner was installed in CAMI. The nanoScan PET/CT has the highest spatial resolution on the market at 0.3 mm. The nanoScan’s 11 cm bore size is suitable for imaging mice and rats. The LYSO:Ce based detectors have > 6% sensitivity with image quantification accuracy over 97%. Attenuation correction is accomplished with the CT module, which can image at 10 µm resolution. The GPU based reconstruction is performed during acquisition, with reconstruction often finishing only minutes after acquisition is completed. Therefore the system is capable of high throughput without compromising image quality.